MEDS - TRxADE Debt to Book Capitalization Ratio

Graphic logo of trxadehealth.com (MEDS)

Geopolitical tensions and data localization requirements are hindering the expansion of the TRxADE HEALTH, Inc. (MEDS) digital pharmacy network into global markets. Meanwhile, the B2B platform for independent pharmacists serves as a cash cow, generating steady cash flow due to user preference for a single-window procurement system. The debt-to-capitalization ratio on the balance sheet reflects the impact of optimizing wholesale transactions, where the value of 0.00 corresponds to the current metric.

TRxADE Health Corp (MEDS) - Debts to Book Value from 07/04/2022 to 10/28/2026
Signature product of TRxADE

Investors must filter out illiquid assets based on strict financial stability criteria. This ratio compares total debt to balance sheet equity, determining the degree of debt load on equity. For TRxADE HEALTH (MEDS), with its weak pricing power and dumping resulting from a model shift, this risk is critical. An analysis of the changing proportion of total debt to balance sheet capitalization reveals dangerous leverage zones. Breaking outside the corridor boundaries signals a threat of default.

Competitors of TRxADE HEALTH, Inc.

Debt to Book Value Veeva Systems Inc.|doximity.com - Debt to Net Assets Ratio|HQY: Debt to Book Capitalization Ratio|WAY - Debt to Book Value|Debts to Book Capitalization CRVL|Privia Medical Group (PRVA) - Debts to Book Value|Debts to Book Capitalization Huron Consulting Group (HURN)|Debt to Book Value Ratio certara.com (CERT)|Debt to Book Value Omnicell|Debt to Book Capital GDRX (GoodRx Inc)|Debt to Book Capitalization Ratio Schrödinger Inc.|PHR - Debt to Net Assets Ratio|Omada Health Inc (OMDA) - Debt to Book Value|EVH - Debt to Book Value Ratio|HSTM: Debts to Book Capitalization|Definitive Healthcare Corp (DH) - Debts to Book Capitalization|Debts to Book Capitalization Consensus (CCSI)|Debt to Book Value Ratio Agilon Health Corp|Absci - Debts to Book Capitalization|Debts to Book Value soyoung.com SY|Debt to Book Value National Research Corp|Debt to Net Assets Ratio Spok Holdings Inc SPOK|Debts to Book Capitalization OptimizeRx Corp. (OPRX)|TBRG - Debt to Net Assets Ratio|Debts to Book Capitalization SLP|SOPHiA GENETICS (SOPH) - Debts to Book Value|HCAT (Health Catalyst) - Debts to Book Capitalization|Debts to Book Capitalization CCLD|Debt to Book Capitalization Ratio Research Solutions (RSSS)|Debt to Book Capitalization Ratio dlhcorp.com DLHC|Debt to Book Value OneMedNet (ONMD)|Debt to Book Capital scienture.com SCNX|Debts to Book Capitalization Healthcare Triangle, Inc. (HCTI)|iSpecimen Inc. (ISPC) - Debt to Net Assets Ratio|Debt to Book Value bullfrogai.com BFRG|SCWorx Inc (WORX) - Debt to Net Assets Ratio|MSPR: Debts to Book Capitalization|Debts to Net Assets ICCT|Debt to Book Capitalization Ratio Orgenesis ORGS|Debt to Book Value Ratio r1rcm.com (RCM)|Sharecare, Inc - Debts to Book Capitalization|STRM - Debt to Book Value|Debt to Book Value SYRA (Syra Health Corp.)|AMEH: Debts to Net Assets|MODN (Model N) - Debt to Book Capitalization Ratio|NextGen Healthcare Inc (NXGN) - Debt to Book Value